search
Back to results

Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered (PSLL)

Primary Purpose

Central Line-Associated Bloodstream Infection (CLABSI), Venous Thromboembolism, Patient Fall

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Patient Safety health information technology
Sponsored by
Brigham and Women's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Central Line-Associated Bloodstream Infection (CLABSI)

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • patients 18-99 years of age

Exclusion Criteria:

  • patients under age 18 years

Sites / Locations

  • Brigham and Women's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Usual Care

Arm Description

Patients and providers on hospital care units where the PSLL patient safety health information technology tools are implemented, during the interventional phase of a stepped wedge randomized trial design.

Patients on hospital care units where the PSLL patient safety health information technology tools have been implemented or are to be implemented, but are not during the usual care phase of a stepped wedge randomized trial design.

Outcomes

Primary Outcome Measures

Clinical Outcomes: Proportion of hospitalizations with any adverse event
Hospitalizations with the presence of any of the following: Patient Falls with Injury, Severe Hypoglycemia, Inpatient or post hospitalization venous thromboembolism, catheter associated urinary tract infection (CAUTI), Central Line Associated Blood Stream Infection (CLABSI), Opioid related severe adverse drug event, hospital acquired pressure ulcer, severe hospital acquired delirium, rapid response related to arrhythmia

Secondary Outcome Measures

Clinical Inertia: When Red flag, % changed to yellow or green during hospitalization
monitoring time for flags to change within patient safety information technology tools
Clinical Inertia:When Red flag, % changed to green during hospitalization
monitoring time for flags to change within patient safety information technology tools
Clinical Inertia: Mean time to resolution of red flags (to green or yellow), days
monitoring time for flags to change within patient safety information technology tools
Clinical Inertia:Mean time to resolution of red flags (to green), days
monitoring time for flags to change within patient safety information technology tools
Patient Falls/ Mobility: % patient days of patients at fall risk due to a gait disturbance on sedatives
Processes of care: % patient days of patients at fall risk due to a gait disturbance on sedatives
Patient Falls/ Mobility:% pt-days of patients at fall risk due to a gait disturbance without Physical Therapy consult order
Processes of care: % patient-days of patients at fall risk due to a gait disturbance without Physical Therapy consult order
Code Status: % patient-days on study unit with unconfirmed code status
Processes of care: % patient-days on study unit with unconfirmed code status
Glucose Control: % patients with diabetes or hyperglycemia with order for basal insulin
Processes of care: % patients with diabetes or hyperglycemia with order for basal insulin
Glucose Control: % patients with diabetes or hyperglycemia with orders for basal and nutritional insulin
Processes of care: % patients with diabetes or hyperglycemia with orders for basal and nutritional insulin
Nutrition: % patient-days without any diet order
Processes of care: % patient-days without any diet order
Nutrition: % pt-days NPO with insulin aspart ordered at same time
Processes of care:% pt-days NPO with insulin aspart ordered at same time
Venous thromboembolism (VTE): % pt-days with appropriate prophylaxis ordered based on risk and contraindications
Processes of care: % patient-days with appropriate prophylaxis ordered based on risk and contraindications
Venous thromboembolism (VTE):% pt-days with appropriate prophylaxis administered based on risk and contraindications
Processes of care: % pt-days with appropriate prophylaxis administered based on risk and contraindications
Venous thromboembolism (VTE): % ordered pharmacologic prophylaxis doses administered
Processes of care: % ordered pharmacologic prophylaxis doses administered
Pain Control: % pt-days with MED > 100 mg
Processes of care: % pt-days with MED > 100 mg
Pain Control: % patient-days with opioids ordered and no adjunctive medications ordered
Processes of care: % patient-days with opioids ordered and no adjunctive medications ordered
Pain Control:% pt-days with opioids administered and no Richmond Agitation-Sedation Scale (RASS) score recorded
Processes of care: % pt-days with opioids administered and no Richmond Agitation-Sedation Scale (RASS) score recorded
Antibiotic Management: % patient-days with patients on broad-spectrum gram-positive and broad-spectrum gram-negative antibiotics for > 72 hours
Processes of care: % pt-days with patients on broad-spectrum gram-positive and broad-spectrum gram-negative antibiotics for > 72 hours
Antibiotic Management: % pt-days with pts on broad-spectrum antibiotics for > 72 hours
Processes of care: % patient-days with patients on broad-spectrum antibiotics for > 72 hours
Delirium Management: % patient-days Confusion Assessment Method (CAM) positive
Processes of care: % patient-days Confusion Assessment Method (CAM) positive
Delirium Management: % patient-days of patients at high risk for delirium on sedatives
Processes of care: % patient-days of patients at high risk for delirium on sedatives
Delirium Management: % patient-days of patients at high risk for delirium on ramelteon
Processes of care: % patient-days of patients at high risk for delirium on ramelteon
Delirium Management: % patient-days of patients with hyperactive delirium on neuroleptics
Processes of care: % patient-days of patients with hyperactive delirium on neuroleptics
Vascular Access: % patient-days with central line in place
Processes of care: % patient-days with central line in place
Foley Care: % patient-days with Foley catheter in place
Processes of care: % patient-days with Foley catheter in place
Foley Care: % patient-days with Foley documented but not ordered
Processes of care: % patient-days with Foley documented but not ordered
Foley Care: % patient-days with Foley documented but Nurse Driven Protocol (NDP) not ordered
Processes of care: % patient-days with Foley documented but NDP not ordered
Telemetry: % patient-days of high risk patients without any telemetry
Processes of care: % patient-days of high risk patients without any telemetry bottom page 5 mock tables
Telemetry: % patient-days of low risk patients on telemetry > 72h
Processes of care: % patient-days of low risk patients on telemetry > 72h
Bowel Regimen: % pt-days of patients on opioids and no bowel regimen ordered
Processes of care: % pt-days of patients on opioids and no bowel regimen ordered
Bowel Regimen:% patient-days where on opioids, no bowel movement 2 or more days, and no bowel regimen administered
Processes of care: % patient-days where on opioids, no bowel movement 2 or more days, and no bowel regimen administered
Fall / Mobility: Patient Falls based on safety reports per 1000 patient-days
Safety Outcomes: Patient Falls based on safety reports per 1000 patient-days
Fall / Mobility: Falls with injury based on safety reports per 1000 patient-days
Safety Outcomes: Falls with injury based on safety reports per 1000 patient-days
Glucose Control: Patient-day-weighted mean glucose
Safety Outcomes: Patient-day-weighted mean glucose
Glucose Control: Proportion of glucose readings 70-180 mg/dL, mean per patient
Safety Outcomes: Proportion of glucose readings 70-180 mg/dL, mean per patient
Glucose Control: Proportion of patient-days with hypoglycemia
Safety Outcomes: Proportion of patient-days with hypoglycemia
Glucose Control: Proportion of patient-days with severe hypoglycemia
Safety Outcomes: Proportion of patient-days with severe hypoglycemia
Venous Thromboembolism: proportion of hospitalizations with hospital-acquired VTE
Safety Outcomes: proportion of hospitalizations with hospital-acquired VTE
Venous Thromboembolism: proportion of hospitalizations with VTE within 30 days of discharge
Safety Outcomes: proportion of hospitalizations with VTE within 30 days of discharge
Pain Control: proportion of hospitalizations with opioid induced depression of consciousness or respiration
Safety Outcomes: proportion of hospitalizations with opioid induced depression of consciousness or respiration
Pain Control: proportion of hospitalizations of patients on opioids who required narcan
Safety Outcomes: proportion of hospitalizations of patients on opioids who required narcan
Pain Control: proportion of hospitalizations with severe opioid-related adverse drug event
Safety Outcomes: proportion of patients on opioids who had rapid response, code blue, ICU transfer, Bipap, mechanical ventilation
Pain Control: proportion of hospitalizations of patients on opioids with any opioid-related Adverse Drug Event
Safety Outcomes: proportion of hospitalizations of patients on opioids with any opioid-related Adverse Drug Event
Pressure Ulcers: proportion of hospitalizations with hospital-acquired pressure ulcer
Safety outcomes: proportion of hospitalizations with hospital-acquired pressure ulcer
Pressure Ulcers: proportion of hospitalizations with pressure ulcer worsening in stage from admission to discharge
Safety outcomes: proportion of hospitalizations with hospital-acquired pressure ulcer worsening in stage from admission to discharge
Delirium Management: proportion of hospitalizations requiring mechanical restraints
Safety outcomes: proportion of hospitalizations requiring mechanical restraints
Delirium Management: proportion of hospitalizations requiring code gray and requiring security
Safety outcomes: proportion of hospitalizations requiring code gray and requiring security
Vascular Access: Central Line Associated Blood Stream Infection (CLABSI) per 1000 patient-days
Safety outcomes: Central Line Associated Blood Stream Infection (CLABSI) per 1000 patient-days
Foley Care: Central Line Associate Urinary Tract Infection per 1000 patient-days
Safety outcomes: Central Line Associate Urinary Tract Infection per 1000 patient-days
Telemetry: proportion of hospitalizations for rapid response for arrhythmia
Safety outcomes: proportion of hospitalizations for rapid response for arrhythmia

Full Information

First Posted
October 24, 2016
Last Updated
July 8, 2019
Sponsor
Brigham and Women's Hospital
Collaborators
Northeastern University
search

1. Study Identification

Unique Protocol Identification Number
NCT02969343
Brief Title
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
Acronym
PSLL
Official Title
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
April 2015 (Actual)
Primary Completion Date
December 2018 (Actual)
Study Completion Date
December 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital
Collaborators
Northeastern University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (PSLL) focuses on developing health information technology (HIT) tools to engage patients, family, and professional care team members in reliable identification, assessment, and reduction of patient safety threats in real-time, before they manifest in actual harm.
Detailed Description
The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (PSLL) will develop systems approaches to integrating health information technology (HIT), stakeholder engagement mechanisms, and process design/engineering methods focused on patient safety, development and enhancement of tools, health care system interventions, and translation into practice. The three technological toolkits to be developed as part of the Patient Safety Learning Laboratory (PSLL) are:1) Patient-centered Fall Prevention Toolkit which aims to engage patients and their family caregivers in the design of HIT tools to prevent patient falls and related injuries during an acute hospitalization; 2) Patient Safety Checklist Tool to improve patient safety and quality outcomes, provider efficiency, and team communication; and 3) MySafeCare Patient Safety Reporting System which aims to iteratively develop and evaluate the impact of a patient safety reporting system on patient safety and fosters a health system focused on collaborative learning. The Brigham and Women's Patient Safety Learning Laboratory (BWH PSLL) will establish a vibrant learning ecosystem of health services, informatics, and systems engineering researchers, collaborating with patients and family for evolving and applying these approaches to adverse event prevention in hospitalized patients. In addition, a Systems Engineering, Usability, and Integration (SEUI) Core will leverage health systems engineering approaches to develop and provide a system-wide methodology to aid in the successful implementation and improvement of Health Information Technology (HIT) tools and a model known as the Patient SatisfActive® will be developed, tested, and refined to create a culture of patient- and family-centered care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Central Line-Associated Bloodstream Infection (CLABSI), Venous Thromboembolism, Patient Fall, Catheter-Associated Infection, Severe Hypoglycemia, Opioid-Related Severe Adverse Drug Event, Hospital Acquired Pressure Ulcer, Adverse Drug Event, Severe Hospital Acquired Delerium, Rapid Response Related to Arrhythmia

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
21000 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Patients and providers on hospital care units where the PSLL patient safety health information technology tools are implemented, during the interventional phase of a stepped wedge randomized trial design.
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Patients on hospital care units where the PSLL patient safety health information technology tools have been implemented or are to be implemented, but are not during the usual care phase of a stepped wedge randomized trial design.
Intervention Type
Behavioral
Intervention Name(s)
Patient Safety health information technology
Intervention Description
Patient safety technology toolkits on hospital care units
Primary Outcome Measure Information:
Title
Clinical Outcomes: Proportion of hospitalizations with any adverse event
Description
Hospitalizations with the presence of any of the following: Patient Falls with Injury, Severe Hypoglycemia, Inpatient or post hospitalization venous thromboembolism, catheter associated urinary tract infection (CAUTI), Central Line Associated Blood Stream Infection (CLABSI), Opioid related severe adverse drug event, hospital acquired pressure ulcer, severe hospital acquired delirium, rapid response related to arrhythmia
Time Frame
up to 21 months
Secondary Outcome Measure Information:
Title
Clinical Inertia: When Red flag, % changed to yellow or green during hospitalization
Description
monitoring time for flags to change within patient safety information technology tools
Time Frame
up to 21 months
Title
Clinical Inertia:When Red flag, % changed to green during hospitalization
Description
monitoring time for flags to change within patient safety information technology tools
Time Frame
up to 21 months
Title
Clinical Inertia: Mean time to resolution of red flags (to green or yellow), days
Description
monitoring time for flags to change within patient safety information technology tools
Time Frame
up to 21 months
Title
Clinical Inertia:Mean time to resolution of red flags (to green), days
Description
monitoring time for flags to change within patient safety information technology tools
Time Frame
up to 21 months
Title
Patient Falls/ Mobility: % patient days of patients at fall risk due to a gait disturbance on sedatives
Description
Processes of care: % patient days of patients at fall risk due to a gait disturbance on sedatives
Time Frame
up to 21 months
Title
Patient Falls/ Mobility:% pt-days of patients at fall risk due to a gait disturbance without Physical Therapy consult order
Description
Processes of care: % patient-days of patients at fall risk due to a gait disturbance without Physical Therapy consult order
Time Frame
up to 21 months
Title
Code Status: % patient-days on study unit with unconfirmed code status
Description
Processes of care: % patient-days on study unit with unconfirmed code status
Time Frame
up to 21 months
Title
Glucose Control: % patients with diabetes or hyperglycemia with order for basal insulin
Description
Processes of care: % patients with diabetes or hyperglycemia with order for basal insulin
Time Frame
up to 21 months
Title
Glucose Control: % patients with diabetes or hyperglycemia with orders for basal and nutritional insulin
Description
Processes of care: % patients with diabetes or hyperglycemia with orders for basal and nutritional insulin
Time Frame
up to 21 months
Title
Nutrition: % patient-days without any diet order
Description
Processes of care: % patient-days without any diet order
Time Frame
up to 21 months
Title
Nutrition: % pt-days NPO with insulin aspart ordered at same time
Description
Processes of care:% pt-days NPO with insulin aspart ordered at same time
Time Frame
up to 21 months
Title
Venous thromboembolism (VTE): % pt-days with appropriate prophylaxis ordered based on risk and contraindications
Description
Processes of care: % patient-days with appropriate prophylaxis ordered based on risk and contraindications
Time Frame
up to 21 months
Title
Venous thromboembolism (VTE):% pt-days with appropriate prophylaxis administered based on risk and contraindications
Description
Processes of care: % pt-days with appropriate prophylaxis administered based on risk and contraindications
Time Frame
up to 21 months
Title
Venous thromboembolism (VTE): % ordered pharmacologic prophylaxis doses administered
Description
Processes of care: % ordered pharmacologic prophylaxis doses administered
Time Frame
up to 21 months
Title
Pain Control: % pt-days with MED > 100 mg
Description
Processes of care: % pt-days with MED > 100 mg
Time Frame
up to 21 months
Title
Pain Control: % patient-days with opioids ordered and no adjunctive medications ordered
Description
Processes of care: % patient-days with opioids ordered and no adjunctive medications ordered
Time Frame
up to 21 months
Title
Pain Control:% pt-days with opioids administered and no Richmond Agitation-Sedation Scale (RASS) score recorded
Description
Processes of care: % pt-days with opioids administered and no Richmond Agitation-Sedation Scale (RASS) score recorded
Time Frame
up to 21 months
Title
Antibiotic Management: % patient-days with patients on broad-spectrum gram-positive and broad-spectrum gram-negative antibiotics for > 72 hours
Description
Processes of care: % pt-days with patients on broad-spectrum gram-positive and broad-spectrum gram-negative antibiotics for > 72 hours
Time Frame
up to 21 months
Title
Antibiotic Management: % pt-days with pts on broad-spectrum antibiotics for > 72 hours
Description
Processes of care: % patient-days with patients on broad-spectrum antibiotics for > 72 hours
Time Frame
up to 21 months
Title
Delirium Management: % patient-days Confusion Assessment Method (CAM) positive
Description
Processes of care: % patient-days Confusion Assessment Method (CAM) positive
Time Frame
up to 21 months
Title
Delirium Management: % patient-days of patients at high risk for delirium on sedatives
Description
Processes of care: % patient-days of patients at high risk for delirium on sedatives
Time Frame
up to 21 months
Title
Delirium Management: % patient-days of patients at high risk for delirium on ramelteon
Description
Processes of care: % patient-days of patients at high risk for delirium on ramelteon
Time Frame
up to 21 months
Title
Delirium Management: % patient-days of patients with hyperactive delirium on neuroleptics
Description
Processes of care: % patient-days of patients with hyperactive delirium on neuroleptics
Time Frame
up to 21 months
Title
Vascular Access: % patient-days with central line in place
Description
Processes of care: % patient-days with central line in place
Time Frame
up to 21 months
Title
Foley Care: % patient-days with Foley catheter in place
Description
Processes of care: % patient-days with Foley catheter in place
Time Frame
up to 21 months
Title
Foley Care: % patient-days with Foley documented but not ordered
Description
Processes of care: % patient-days with Foley documented but not ordered
Time Frame
up to 21 months
Title
Foley Care: % patient-days with Foley documented but Nurse Driven Protocol (NDP) not ordered
Description
Processes of care: % patient-days with Foley documented but NDP not ordered
Time Frame
up to 21 months
Title
Telemetry: % patient-days of high risk patients without any telemetry
Description
Processes of care: % patient-days of high risk patients without any telemetry bottom page 5 mock tables
Time Frame
up to 21 months
Title
Telemetry: % patient-days of low risk patients on telemetry > 72h
Description
Processes of care: % patient-days of low risk patients on telemetry > 72h
Time Frame
up to 21 months
Title
Bowel Regimen: % pt-days of patients on opioids and no bowel regimen ordered
Description
Processes of care: % pt-days of patients on opioids and no bowel regimen ordered
Time Frame
up to 21 months
Title
Bowel Regimen:% patient-days where on opioids, no bowel movement 2 or more days, and no bowel regimen administered
Description
Processes of care: % patient-days where on opioids, no bowel movement 2 or more days, and no bowel regimen administered
Time Frame
up to 21 months
Title
Fall / Mobility: Patient Falls based on safety reports per 1000 patient-days
Description
Safety Outcomes: Patient Falls based on safety reports per 1000 patient-days
Time Frame
up to 21 months
Title
Fall / Mobility: Falls with injury based on safety reports per 1000 patient-days
Description
Safety Outcomes: Falls with injury based on safety reports per 1000 patient-days
Time Frame
up to 21 months
Title
Glucose Control: Patient-day-weighted mean glucose
Description
Safety Outcomes: Patient-day-weighted mean glucose
Time Frame
up to 21 months
Title
Glucose Control: Proportion of glucose readings 70-180 mg/dL, mean per patient
Description
Safety Outcomes: Proportion of glucose readings 70-180 mg/dL, mean per patient
Time Frame
up to 21 months
Title
Glucose Control: Proportion of patient-days with hypoglycemia
Description
Safety Outcomes: Proportion of patient-days with hypoglycemia
Time Frame
up to 21 months
Title
Glucose Control: Proportion of patient-days with severe hypoglycemia
Description
Safety Outcomes: Proportion of patient-days with severe hypoglycemia
Time Frame
up to 21 months
Title
Venous Thromboembolism: proportion of hospitalizations with hospital-acquired VTE
Description
Safety Outcomes: proportion of hospitalizations with hospital-acquired VTE
Time Frame
up to 21 months
Title
Venous Thromboembolism: proportion of hospitalizations with VTE within 30 days of discharge
Description
Safety Outcomes: proportion of hospitalizations with VTE within 30 days of discharge
Time Frame
up to 21 months
Title
Pain Control: proportion of hospitalizations with opioid induced depression of consciousness or respiration
Description
Safety Outcomes: proportion of hospitalizations with opioid induced depression of consciousness or respiration
Time Frame
up to 21 months
Title
Pain Control: proportion of hospitalizations of patients on opioids who required narcan
Description
Safety Outcomes: proportion of hospitalizations of patients on opioids who required narcan
Time Frame
up to 21 months
Title
Pain Control: proportion of hospitalizations with severe opioid-related adverse drug event
Description
Safety Outcomes: proportion of patients on opioids who had rapid response, code blue, ICU transfer, Bipap, mechanical ventilation
Time Frame
up to 21 months
Title
Pain Control: proportion of hospitalizations of patients on opioids with any opioid-related Adverse Drug Event
Description
Safety Outcomes: proportion of hospitalizations of patients on opioids with any opioid-related Adverse Drug Event
Time Frame
up to 21 months
Title
Pressure Ulcers: proportion of hospitalizations with hospital-acquired pressure ulcer
Description
Safety outcomes: proportion of hospitalizations with hospital-acquired pressure ulcer
Time Frame
up to 21 months
Title
Pressure Ulcers: proportion of hospitalizations with pressure ulcer worsening in stage from admission to discharge
Description
Safety outcomes: proportion of hospitalizations with hospital-acquired pressure ulcer worsening in stage from admission to discharge
Time Frame
up to 21 months
Title
Delirium Management: proportion of hospitalizations requiring mechanical restraints
Description
Safety outcomes: proportion of hospitalizations requiring mechanical restraints
Time Frame
up to 21 months
Title
Delirium Management: proportion of hospitalizations requiring code gray and requiring security
Description
Safety outcomes: proportion of hospitalizations requiring code gray and requiring security
Time Frame
up to 21 months
Title
Vascular Access: Central Line Associated Blood Stream Infection (CLABSI) per 1000 patient-days
Description
Safety outcomes: Central Line Associated Blood Stream Infection (CLABSI) per 1000 patient-days
Time Frame
up to 21 months
Title
Foley Care: Central Line Associate Urinary Tract Infection per 1000 patient-days
Description
Safety outcomes: Central Line Associate Urinary Tract Infection per 1000 patient-days
Time Frame
up to 21 months
Title
Telemetry: proportion of hospitalizations for rapid response for arrhythmia
Description
Safety outcomes: proportion of hospitalizations for rapid response for arrhythmia
Time Frame
up to 21 months
Other Pre-specified Outcome Measures:
Title
Provider perceptions of safety, communication based on Agency for Healthcare Research and Quality (AHRQ) patient safety climate survey
Description
perceived teamwork climate on hospital care units based on Agency for Healthcare Research and Quality (AHRQ) patient safety climate survey
Time Frame
up to 21 months
Title
Patient activation, engagement, satisfaction based on Patient Activation Measure (PAM 13)
Description
Patient and caregiver perceptions of how well clinical team kept them safe based on Patient Activation Measure (PAM 13)
Time Frame
up to 21 months
Title
Usability of tools/ technology based on Health iTues survey
Description
usability of technology- ease of use based on Health iTues survey
Time Frame
up to 21 months
Title
Effects on workflow
Description
cognitive burden based on direct observations
Time Frame
up to 21 months
Title
Adherence to PSLL patient safety information technology tools
Description
use of tool by providers and patients
Time Frame
up to 21 months
Title
Health care utilization
Description
Length of stay of patients
Time Frame
up to 21 months
Title
Patient Reported Safety Concerns- MySafeCare reporting tool
Description
Rate of submissions into the MySafeCare reporting tool per 1000 patient days (confidence interval)
Time Frame
up to 21 months
Title
Proportion of hospitalizations with code blue or rapid response
Description
Other Clinical Outcomes: Proportion of hospitalizations with cardio-respiratory code or rapid response
Time Frame
up to 21 months
Title
Proportion of hospitalizations with ICU transfer
Description
Other Clinical Outcomes: Proportion of hospitalizations with ICU transfer
Time Frame
up to 21 months
Title
Average time of discharge
Description
time of discharge averaged
Time Frame
up to 21 months
Title
Patient Activation Measure (PAM-13)
Description
Patient Activation as measured by the PAM 13 survey
Time Frame
up to 21 months
Title
30-day non-elective readmission
Description
30-day non-elective readmission
Time Frame
up to 21 months
Title
Patient Satisfaction (HCAHPS)
Description
Patient Satisfaction as measured by the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS)
Time Frame
up to 21 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: patients 18-99 years of age Exclusion Criteria: patients under age 18 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David W Bates, MD MSc
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33201236
Citation
Dykes PC, Burns Z, Adelman J, Benneyan J, Bogaisky M, Carter E, Ergai A, Lindros ME, Lipsitz SR, Scanlan M, Shaykevich S, Bates DW. Evaluation of a Patient-Centered Fall-Prevention Tool Kit to Reduce Falls and Injuries: A Nonrandomized Controlled Trial. JAMA Netw Open. 2020 Nov 2;3(11):e2025889. doi: 10.1001/jamanetworkopen.2020.25889.
Results Reference
derived

Learn more about this trial

Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered

We'll reach out to this number within 24 hrs